Details for Patent: 5,658,590
✉ Email this page to a colleague
Summary for Patent: 5,658,590
Title: | Treatment of attention-deficit/hyperactivity disorder |
Abstract: | Tomoxetine, a norepinephrine uptake inhibitor, is used to treat attention-deficit/hyperactivity disorder. |
Inventor(s): | Heiligenstein; John H. (Indianapolis, IN), Tollefson; Gary D. (Indianapolis, IN) |
Assignee: | Eli Lilly and Company (Indianapolis, IN) |
Application Number: | 08/371,341 |
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 5,658,590
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,658,590
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 0721777 | ⤷ Sign Up | SPC/GB04/033 | United Kingdom | ⤷ Sign Up |
European Patent Office | 0721777 | ⤷ Sign Up | 300180 | Netherlands | ⤷ Sign Up |
European Patent Office | 0721777 | ⤷ Sign Up | 91238 | Luxembourg | ⤷ Sign Up |
European Patent Office | 0721777 | ⤷ Sign Up | SPC012/2006 | Ireland | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |